Featured Research

from universities, journals, and other organizations

Two repressor genes identified as essential for placental development

Date:
April 16, 2012
Source:
Ohio State University Medical Center
Summary:
Two particular repressor genes in a family of regulatory genes are vital for controlling cell proliferation during development of the placenta. Their absence in stem cells results in a placenta made up of overcrowded and poorly organized cells that cannot properly transport oxygen and nutrients or support normal embryonic development. The study show how these genes control cell proliferation in living animals.

The E2F family of genes is thought to play a crucial role in regulating cell proliferation. It is unclear how these genes carry out their function and interact with one another in intact animals. This study shows that two E2F repressor genes are essential for a functional placenta and for balancing the effect of an E2F activator gene.

Two particular repressor genes in a family of regulatory genes are vital for controlling cell proliferation during development of the placenta, according to a new study by researchers with the Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James).

The two genes are called E2f7 and E2f8. Their absence in stem cells results in a placenta made up of overcrowded and poorly organized cells that cannot properly transport oxygen and nutrients or support normal embryonic development.

When placental stem cells were also missing a third gene, the activating gene called E2f3a, the placental defects were corrected and embryos carried to birth.

The study, published in the journal Developmental Cell, shows at the molecular level how these E2Fs control cell proliferation in intact animals, the researchers say.

"The findings provide insight into the role of these two repressor genes," says principal investigators Gustavo Leone, associate professor of Medicine and associate director of Basic Research at the OSUCCC -- James.

The two genes belong to a family of regulatory genes that, in humans, has eight members. They are all believed to activate or suppress other genes to control cell division and proliferation in both normal and cancer cells. But which genes they regulate and how they interact with one another in living animals is poorly understood.

"E2F regulatory genes have been thought to be important for a long time, but with so many of them, it's been hard to tell which one is doing what," Leone says.

"Here, we show that the repressors E2f7 and E2f8 are essential for the development of an intact, functional, placenta, and that they balance out the effects of the activating gene E2f3a," Leone says. "Because these two repressors are important for proliferation, they may also play an important role in suppressing tumor development."

For this study, Leone and his colleagues used animal models that lacked one or more of the three E2F genes in trophoblast stem cells, which give rise to the placenta.

Earlier work led by Leone has shown that in some cases, one E2F gene can be an activator in some tissues and a repressor in others.


Story Source:

The above story is based on materials provided by Ohio State University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Madhu M. Ouseph, Jing Li, Hui-Zi Chen, Thierry Pécot, Pamela Wenzel, John C. Thompson, Grant Comstock, Veda Chokshi, Morgan Byrne, Braxton Forde, Jean-Leon Chong, Kun Huang, Raghu Machiraju, Alain de Bruin, Gustavo Leone. Atypical E2F Repressors and Activators Coordinate Placental Development. Developmental Cell, 2012; 22 (4): 849 DOI: 10.1016/j.devcel.2012.01.013

Cite This Page:

Ohio State University Medical Center. "Two repressor genes identified as essential for placental development." ScienceDaily. ScienceDaily, 16 April 2012. <www.sciencedaily.com/releases/2012/04/120416125318.htm>.
Ohio State University Medical Center. (2012, April 16). Two repressor genes identified as essential for placental development. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/04/120416125318.htm
Ohio State University Medical Center. "Two repressor genes identified as essential for placental development." ScienceDaily. www.sciencedaily.com/releases/2012/04/120416125318.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins